Letti Vick, Registered Nurse - Home Health Medicare: Not Enrolled in Medicare Practice Location: 4636 County Road 112 N, Overton, TX 75684 Phone: 903-722-3055 |
News Archive
By a decisive margin of 74-21 percent, Americans support former First Lady Nancy Reagan's call for the Bush White House to lift restrictions on stem cell research in order to look for possible treatments for the Alzheimer's disease
Humacyte, Inc. and Xcellerex, Inc. have entered into an initial strategic collaboration for Xcellerex to develop a novel manufacturing process that will enable the production of Humacyte's lead regenerative medicine product using Xcellerex's XDR single use bioreactor system in its FlexFactory®. Humacyte's product is a large diameter vascular graft that is based on its innovative and proprietary platform technology for engineering human, extracellular matrix-based tissues that have properties that are similar to native tissues.
Validus Pharmaceuticals LLC, together with Wood Creek Capital Management, LLC ("Wood Creek"), announced today the acquisition of the U.S. rights to several well-known product lines from Sanofi US: Anzemet (dolasetron mesylate) Injection and Tablets, Claforan (cefotaxime) Injection/IM/IV, Demerol (meperidine hydrochloride) Tablets, Drisdol (ergocalciferol) Capsules and Oral Solution, Hiprex (methenamine hippurate) Tablets, Lasix (furosemide) Tablets, Norpramin (desipramine hydrochloride) Tablets and Trental (pentoxifylline) Tablets.
Startling new statistics on the worldwide prevalence of Alzheimer's disease and related dementias are being released today as countries across the globe join together in recognition of World Alzheimer's Day.
› Verified 8 days ago